Editorial Commentary: Surgical Therapy for Staphylococcus aureus Prosthetic Valve Endocarditis: Proceed With Caution (Caveat Emptor)
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
(See the Major Article by Chirouze et al on pages 741–9.) Embraced by treatment guidelines from various organizations (eg, the American Heart Association, the European Society of Cardiology), the role of surgery in the treatment of left-sided infective endocarditis (IE) has been expanding in recent decades. The generally accepted indications for surgical intervention are based almost entirely on observational studies, and in some instances on expert opinion. Recent studies utilizing large datasets of patients with native valve IE have used sophisticated analytic techniques to assess the benefits of surgical treatment of IE. These studies adjust for treatment selection bias (propensity for surgery), prognostic variables, and comorbidities, as well as survival bias expressed as the time of surgery. At least 2 of these investigations have demonstrated survival benefits of early valve surgery (EVS) in terms of mortality in hospital and/or at 6 months after surgery [1, 2]. Prosthetic valve infective endocarditis (PVIE) represents a special management category, given its distinct pathogenesis and severe complications, especially in early PVIE (ie, within 12 months after valve implantation). Current guidelines [3, 4] and some studies advocate aggressive surgical intervention for patients with early PVIE, particularly when caused by staphylococci or complicated by severe heart failure (New York Heart Association [NYHA] class III–IV), valve dehiscence, or paravalvular abscess. At large tertiary hospitals with cardiac surgical programs, surgical intervention occurs in 42%–49% of patients with PVIE [5, 6]. This is not unexpected given the above-mentioned severe complications, which are unlikely to respond to antimicrobial therapy alone [5, 7]. Nevertheless, Lalani et al [7] were unable to demonstrate reduced in-hospital or 1-year mortality with valve replacement compared with medical therapy for PVIE. Using data collected prospectively between 1 January 2000 and 31 December 2006 by the multicenter International Collaborative on Endocarditis–Prospective Cohort Study (ICE-PCS), these investigators examined mortality rates among 1025 patients with definite PVIE, 490 (47.8%) of whom underwent surgery during their index hospitalization. After controlling for therapy selection bias using the inverse probability of treatment weighting, a propensity variable, in regression models, EVS was associated with lower mortality during hospitalization and at 1 year. However, when controlling for both treatment selection, as well as for survivor bias by including surgery as a time-dependent variable in a Cox proportional hazards model, the survival benefit of EVS was lost.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Data from nonrandomized trials from a single-center experience 250 and an international collaboration 251 support the notion 252 that early valve surgery may not be beneficial in all patients with native or PVE caused by S aureus.”
Citations
Cites
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Self-citationEarly Surgery versus Conventional Treatment for Infective Endocarditis
Kang, D.-H., Kim, Y.-J., Kim, S.-H., Sun, B. J., Kim, D.-H., Yun, S.-C., Song, J.-M., Choo, S. J., Chung, C.-H., Song, J.-K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112843 · Cited by 902
Contemporary Clinical Profile and Outcome of Prosthetic Valve Endocarditis
Wang, A. (2007) · JAMA · doi:10.1001/jama.297.12.1354 · Cited by 703
Lalani, T., Cabell, C. H., Benjamin, D. K., Lasca, O., Naber, C., Fowler, V. G., Corey, G. R., Chu, V. H., Fenely, M., Pachirat, O., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.864488 · Cited by 308
Lalani, T. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.8203 · Cited by 284
Bannay, A., Hoen, B., Duval, X., Obadia, J.-F., Selton-Suty, C., Le Moing, V., Tattevin, P., Iung, B., Delahaye, F., Alla, F., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehp008 · Cited by 182
Prosthetic valve endocarditis: who needs surgery? A multicentre study of 104 cases
Habib, G., Tribouilloy, C., Thuny, F., Giorgi, R., Brahim, A., Amazouz, M., Remadi, J.-P., Nadji, G., Casalta, J.-P., Coviaux, F., et al. (2005) · Heart · doi:10.1136/hrt.2004.046177 · Cited by 181
Wang, A., Pappas, P., Anstrom, K. J., Abrutyn, E., Fowler, V. G., Hoen, B., Miro, J. M., Corey, G. R., Olaison, L., Stafford, J. A., et al. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.01.023 · Cited by 159
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165563 · Cited by 159
Self-citation
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Self-citationPettersson, G. B., Coselli, J. S., Pettersson, G. B., Coselli, J. S., Hussain, S. T., Griffin, B., Blackstone, E. H., Gordon, S. M., LeMaire, S. A., & Woc-Colburn, L. E. (2017) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2016.09.093 · Cited by 410
JCS 2017 Guideline on Prevention and Treatment of Infective Endocarditis
Nakatani, S., Ohara, T., Ashihara, K., Izumi, C., Iwanaga, S., Eishi, K., Okita, Y., Daimon, M., Kimura, T., Toyoda, K., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0549 · Cited by 179
Sáez, C., Sarriá, C., Vilacosta, I., Olmos, C., López, J., García-Granja, P. E., Fernández, C., Cuevas, C. D. L., Reyes, G., Domínguez, L., et al. (2019) · Medicine · doi:10.1097/md.0000000000016903 · Cited by 3
Early Valve Surgery in Staphylococcal Prosthetic Valve Endocarditis: Still Case-by-Case
Ampel, N. M. (2015) · Journal watch · doi:10.1056/nejm-jw.na37130
Metadata
- Authors
- Karchmer, A. W., & Bayer, A. S.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- University of California, Los Angeles (US)
- Corresponding author
- Karchmer, A. W.
- ORCID
- Karchmer, A. W.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-11-10
- Volume
- 60
- Issue
- 5
- Pages
- 750-752
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2126698551
- Semantic Scholar
- a54751ee5ecfb285e678d2b40f42dadc30f7057e
- Cited by
- 5
- References
- 16
- Citations by year
- 2019: 2 · 2017: 1 · 2015: 2
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01 AI-039108-17, R01AI039108)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Surgery › Orthopedic Infections and Treatments
- Keywords
- prosthetic valve endocarditis, Staphylococcus aureus, infective endocarditis surgery, mortality, treatment selection bias, paravalvular abscess, valve dehiscence, heart failure, surgical indications, antibiotic therapy, left-sided endocarditis, paravalvular leak
- MeSH terms
- Endocarditis, Female, Heart Valves, Humans, Male, Staphylococcal Infections, Prosthesis-Related Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.